Search Results - "Shaw, Heather"
-
1
Beyond Self-Report: Tools to Compare Estimated and Real-World Smartphone Use
Published in PloS one (28-10-2015)“…Psychologists typically rely on self-report data when quantifying mobile phone usage, despite little evidence of its validity. In this paper we explore the…”
Get full text
Journal Article -
2
Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications
Published in European journal of cancer (1990) (01-10-2020)“…Immune-checkpoint inhibitors (ICIs) have revolutionised the therapeutic landscape for multiple malignancies and the health of the gut microbiome (GM) is…”
Get full text
Journal Article -
3
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Published in Nature medicine (01-03-2022)“…The composition of the gut microbiome has been associated with clinical responses to immune checkpoint inhibitor (ICI) treatment, but there is limited…”
Get full text
Journal Article -
4
Risk factors and prodromal eating pathology
Published in Journal of child psychology and psychiatry (01-04-2010)“…Prospective studies have identified factors that increase risk for eating pathology onset, including perceived pressure for thinness, thin‐ideal…”
Get full text
Journal Article -
5
Dissonance and Healthy Weight Eating Disorder Prevention Programs: Long-Term Effects From a Randomized Efficacy Trial
Published in Journal of consulting and clinical psychology (01-04-2008)“…Adolescent girls with body dissatisfaction ( N = 481, SD = 1.4) were randomized to a dissonance-based thin-ideal internalization reduction program, healthy…”
Get full text
Journal Article -
6
A meta-analytic review of eating disorder prevention programs: encouraging findings
Published in Annual review of clinical psychology (01-01-2007)“…This meta-analytic review found that 51% of eating disorder prevention programs reduced eating disorder risk factors and 29% reduced current or future eating…”
Get full text
Journal Article -
7
Radiation Risks to Adult Patients Undergoing Modified Barium Swallow Studies
Published in Dysphagia (01-12-2019)“…Modified Barium Swallow Studies (MBSSs) are a fluoroscopic exam that exposes patients to ionizing radiation. Even though radiation exposure from MBSSs is…”
Get full text
Journal Article -
8
Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
Published in Therapeutic Advances in Medical Oncology (01-01-2023)“…Tebentafusp is a first-in-class immunotherapy agent that comprises an engineered T-cell receptor targeting a gp100 epitope presented by human leukocyte…”
Get full text
Book Review Journal Article -
9
Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis
Published in Melanoma research (01-02-2019)“…Immune checkpoint inhibitor (IO) induced colitis is primarily managed with corticosteroids. Most patients have a rapid resolution of symptoms and do not…”
Get full text
Journal Article -
10
Role of body dissatisfaction in the onset and maintenance of eating pathology: A synthesis of research findings
Published in Journal of psychosomatic research (01-11-2002)“…Objective: Recent findings implicate body dissatisfaction in the development and maintenance of eating pathology. This paper reviews theory and empirical…”
Get full text
Journal Article -
11
Efficacy Trial of a Selective Prevention Program Targeting Both Eating Disorders and Obesity Among Female College Students: 1- and 2-Year Follow-Up Effects
Published in Journal of consulting and clinical psychology (01-02-2013)“…Objective: Evaluate the effects of a prevention program targeting both eating disorders and obesity at 1- and 2-year follow-ups. Method: Female college…”
Get full text
Journal Article -
12
Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors
Published in Journal of clinical oncology (01-09-2010)“…Preclinical data have demonstrated that BIBW 2992 is a potent irreversible inhibitor of ErbB1 (EGFR/HER1) and mutated ErbB1 receptors including the T790M…”
Get full text
Journal Article -
13
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Published in Journal of clinical oncology (01-11-2005)“…ABI-007, the first biologically interactive albumin-bound paclitaxel in a nanameter particle, free of solvents, was compared with polyethylated castor…”
Get full text
Journal Article -
14
The One-Year Attributable Cost of Post-stroke Dysphagia
Published in Dysphagia (01-10-2014)“…With the recent emphasis on evidence-based practice and healthcare reform, understanding the cost of dysphagia management has never been more important. It is…”
Get full text
Journal Article -
15
Testing Mediators of Intervention Effects in Randomized Controlled Trials: An Evaluation of Two Eating Disorder Prevention Programs
Published in Journal of consulting and clinical psychology (01-02-2007)“…The authors investigated mediators hypothesized to account for the effects of 2 eating disorder prevention programs using data from 355 adolescent girls who…”
Get full text
Journal Article -
16
Predictors of the sustainability for an evidence-based eating disorder prevention program delivered by college peer educators
Published in Implementation science : IS (04-07-2024)“…Despite ongoing efforts to introduce evidence-based interventions (EBIs) into mental health care settings, little research has focused on the sustainability of…”
Get full text
Journal Article -
17
Enhancing Efficacy of a Brief Obesity and Eating Disorder Prevention Program: Long-Term Results from an Experimental Therapeutics Trial
Published in Nutrients (01-02-2023)“…: Test whether the efficacy of , an obesity/eating disorder prevention program, is improved by delivering it in single-sex groups and adding food response…”
Get full text
Journal Article -
18
Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab)
Published in Frontiers in immunology (12-07-2024)“…Cemiplimab was licensed in the United Kingdom (UK) in 2019 for the treatment of patients with locally advanced and metastatic CSCC not suitable for curative…”
Get full text
Journal Article -
19
Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
Published in Clinical cancer research (01-10-2007)“…Purpose: This phase I study was undertaken to define the maximum tolerated dose, safety, and pharmacokinetic profile of CP-751,871. Experimental Design: Using…”
Get full text
Journal Article -
20
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Published in Nature medicine (01-03-2024)“…Multiple clinical trials targeting the gut microbiome are being conducted to optimize treatment outcomes for immune checkpoint blockade (ICB). To improve the…”
Get full text
Journal Article